Updated: Oct 11, 2024
The average Inhibikase Therapeutics stock price target is 5.00 with a max estimate of 5.00 and a min estimate of 5.00
Review Inhibikase Therapeutics earnings estimates
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Analyst Ratings Disclaimer
Updated: Oct 11, 2024
No Data